Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation

Abstract

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. Abbreviations: AASLD American Association for the Study of Liver Diseases AUC area under the curve AUROC area under the receiver operating characteristics curve BAR balance of risk BC body composition BMI body mass index CCI comprehensive complication index CDC lavien-Dindo classification CT computed tomography EAD early allograft dysfunction EASL European Association for the Study of the Liver ECD extended criteria donor FFP unitsfresh frozen plasma units HU Hounsfield unit ICH International Conference on Harmonisation ICU Intensive Care Unit KPS Karnofsky Performance Score MELD Model of End-stage Liver Disease OLT orthotopic liver transplantation RBC units red blood cell units ROC receiver operating characteristics SM-RA skeletal muscle radiation attenuation SMI skeletal muscle index SMM skeletal muscle mass SOFT survival outcomes following liver transplantation TEur Thousand Euros UH-RWTH University Hospital of the RWTH University VFA visceral fat area1 Muscle wasting and alterations of body composition are linked to clinical outcomes in numerous medical conditions. The role of myosteatosis in posttransplant outcomes remains to be determined. Here we investigated skeletal muscle mass and myosteatosis as prognostic factors in patients undergoing orthotopic liver transplantation (OLT). The data of 225 consecutive OLT recipients from a prospective database were retrospectively analyzed (May 2010-December 2017). Computed tomography-based skeletal-muscleindex (muscle mass), visceral-fat-area (visceral adiposity), and mean skeletal-muscle-radiation-attenuation (myosteatosis) were calculated using a segmentation tool. Cut-off values of myosteatosis resulted in a good stratification of patients into low-and high-risk groups in terms of morbidity (Clavien-Dindo ≥3b). Patients with myosteatosis had significantly higher complication rates (90-day Comprehensive Complication Index 68 ± 32vs 44 ± 30, P < .001) and also displayed significantly longer intensive care (18 ± 25 vs 11 ± 21 days, P < .001) and hospital stay (56 ± 55 vs 33 ± 24 days, P < .001). Estimated costs were 44% higher compared to patients without myosteatosis. Multivariable analysis identified myosteatosis as an independent prognostic factor for major morbidity (odds ratio: 2.772, confidence interval: 1.516-5.066, P = .001). Adding myosteatosis to the well-established Balance-of-Risk-(BAR) score resulted in an increased prognostic value compared to the original BAR score. Myosteatosis may be a useful parameter to predict perioperative outcome in patients undergoing OLT, supporting the role of muscle quality (myosteatosis) over quantity (muscle mass) in this setting. K E Y W O R D Sbody composition, clinical decision-making, clinical research/practice, complication, liver transpla...

Skeletal Muscle Composition Predicts Outcome in Critically Ill Patients

“…Our data are in line with previous studies demonstrating an association of sarcopenia and an impaired prognosis in patients with nonalcoholic liver disease ( 18 ), liver cirrhosis ( 19 ), cardiovascular ( 20 ), and lung diseases ( 21 ). Furthermore, it was demonstrated that sarcopenia might predict outcome of patients undergoing therapeutic interventions such as transcatheter arterial chemoembolization (TACE) ( 22 ), liver transplantation ( 23 ), or colorectal cancer surgery ( 24 ). Within our study, we not only analyzed the association between sarcopenia and patient’s outcome but also of myosteatosis and patients´ outcome.…”

Low thoracic muscle radiation attenuation is associated with postoperative pneumonia following partial hepatectomy for colorectal metastasis

“…[5][6][7][8][9] In addition, skeletal muscle radiation attenuation (SM-RA) has emerged as a radiological marker indicative of myosteatosis, which has been shown to be predictive of poor outcome following oncological surgery. 2,10,11,48 Myosteatosis is characterized by increased interand intra-myocellular fat stores, which can be influenced by dietary pattern and activity changes. This is related to reduced physical fitness and reduced muscle function.…”

Correlation Between Sarcopenia and Growth Rate of the Future Liver Remnant After Portal Vein Embolization in Patients with Colorectal Liver Metastases

“…Besides general loss of muscle mass, the loss of muscle function is often associated with increased proportions of inter-and intramuscular fat, which is called myosteatosis and represents a subelement of sarcopenia [14]. Myosteatosis has been identified as another important parameter and has also been linked to adverse outcomes in a variety of different diseases such as, e.g., liver cirrhosis and patients undergoing liver surgery [15][16][17].…”